Case report: Magnetic resonance imaging findings in human African trypanosomiasis: A four-year follow-up study in a patient and review of the literature

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 6, 2009, Pages 947-952

  Kager, Piet A ^a   Schipper, Hans G ^a   Stam, Jan ^a   Majoie, Charles B L M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; VALPROIC ACID; ANTITRYPANOSOMAL AGENT;

ADULT; AFRICAN TRYPANOSOMIASIS; ARTICLE; BRAIN DISEASE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOCAL EPILEPSY; HUMAN; LABORATORY TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; FOLLOW UP; PATHOLOGY; REVIEW;

TRYPANOSOMA BRUCEI GAMBIENSE;

ADULT; EFLORNITHINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; TRYPANOCIDAL AGENTS; TRYPANOSOMIASIS, AFRICAN;

EID: 66949163348     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.947     Document Type: Article

References (13)

1. Anonymous, 2006. Human African trypanosomiasis (sleeping sickness): epidemiological update. Wkly Epidemiol Rec 81: 71-80.
2. Lejon V, Boelaert M, Jannin J, Moore A, Búscher P, 2003. The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside Africa. Lancet Infect Dis 3: 804-808. (Pubitemid 37489964)
3. Spinazzola F, D'Amato C, De Felici A, Giannuzzi R, Paglia MG, Struglia C, Tocci G, Visco G, Galgani S, Cotroneo E, 1989. Plasmapheresis for late-stage trypanosomiasis. Lancet 339: 1200. (Pubitemid 19138870)
4. Serrano-Gonzalez C, Velilla I, Fortuno B, Guelbenzu S, Portoles A, 1996. Neuroimaging and efficacy of treatment in advanced African trypanosomiasis. Rev Neurol 24: 1554-1557.
5. Bedat-Millet AL, Charpentier S, Monge-Strauss MF, Woimant F, 2000. Psychiatric presentation of human African trypanosomiasis: overview of diagnostic pitfalls, interest of difluoromethylornithine treatment and contribution of magnetic resonance imaging. Rev Neurol (Paris) 156: 505-509. (Pubitemid 30390011)
6. Sahlas DJ, MacLean JD, Janevski J, Detsky AS, 2002. Clinical problem-solving. Out of Africa. N Engl J Med 347: 749-753.
7. Gill DS, Chatha DS, del Carpio-O'Donovan R, 2003. MR imaging findings in African trypansomiasis. AJNR Am J Neuroradiol 24: 1383-1385. (Pubitemid 37012835)
8. Sabbah P, Brosset C, Imbert P, Bonardel G, Jeandel P, Briant JF, 1997. Human African trypanosomiasis: MRI. Neuroradiology 39: 708-710. (Pubitemid 27425063)
9. Braakman HM, van de Molengraft FJ, Hubert WW, Boerman DH, 2006. Lethal African trypanosomiasis in a traveler: MRI and neuropathology. Neurology 66: 1094-1096. (Pubitemid 44044798)
10. Kumar N, Orenstein R, Uslan DZ, Berbari EF, Klein CJ, Windebank AJ, 2006. Melarsoprol-associated multifocal inflammatory CNS illness in African trypanosomiasis. Neurology 66: 1120-1121. (Pubitemid 44044809)
11. Checkley AM, Pepin J, Gibson WC, Taylor MN, Jager HR, Mabey DC, 2007. Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy. Trans R Soc Trop Med Hyg 101: 523-526. (Pubitemid 46381492)
12. Chappuis F, Loutan L, Simarro P, Lejon V, Buscher P, 2005. Options for field diagnosis of human African trypanosomiasis. Clin Microbiol Rev 18: 133-146. (Pubitemid 40170665)
13. Kennedy PG, 2008. Diagnosing central nervous system trypanosmiasis: two stage or not to stage? Trans R Soc Trop Med Hyg 102: 306-307.